BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2857738)

  • 1. Attenuation of coronary vascular resistance by selective alpha 1-adrenergic blockade in patients with coronary artery disease.
    Kern MJ; Horowitz JD; Ganz P; Gaspar J; Colucci WS; Lorell BH; Barry WH; Mudge GH
    J Am Coll Cardiol; 1985 Apr; 5(4):840-6. PubMed ID: 2857738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of alpha-adrenergic receptor blockade on coronary circulation in conscious dogs.
    Macho P; Hintze TH; Vatner SF
    Am J Physiol; 1982 Jul; 243(1):H94-8. PubMed ID: 6124131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease.
    Kern MJ; Ganz P; Horowitz JD; Gaspar J; Barry WH; Lorell BH; Grossman W; Mudge GH
    Circulation; 1983 Jun; 67(6):1178-85. PubMed ID: 6133636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional coronary vasoconstriction after combined beta-adrenergic and calcium channel blockade in patients with coronary artery disease.
    Kern MJ; Petru MA; Ferry DR; Eilen SD; Barr WK; Porter CB; O'Rourke RA
    J Am Coll Cardiol; 1985 Jun; 5(6):1438-50. PubMed ID: 2860147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alpha-1 adrenergic blockade on regional flow in the ischemic heart.
    Macho P; Domenech RJ
    Acta Physiol Pharmacol Latinoam; 1988; 38(3):319-27. PubMed ID: 2908531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-adrenergic tone in the coronary circulation of the conscious dog.
    Vatner SF
    Fed Proc; 1984 Nov; 43(14):2867-72. PubMed ID: 6092145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reflex increase in coronary vascular resistance in patients with ischemic heart disease.
    Mudge GH; Grossman W; Mills RM; Lesch M; Braunwald E
    N Engl J Med; 1976 Dec; 295(24):1333-7. PubMed ID: 10527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary vascular reactivity and calcium antagonist therapy in patients with angina.
    Perondi R; Saino A; Zanchetti A; Mancia G
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S30-6. PubMed ID: 7603075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
    Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of regional alpha- and beta-blockade on resting and hyperemic coronary blood flow in conscious, unstressed humans.
    Hodgson JM; Cohen MD; Szentpetery S; Thames MD
    Circulation; 1989 Apr; 79(4):797-809. PubMed ID: 2564323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prostacyclin on coronary hemodynamics at rest and in response to cold pressor testing in patients with angina pectoris.
    Ganz P; Gaspar J; Colucci WS; Barry WH; Mudge GH; Alexander RW
    Am J Cardiol; 1984 Jun; 53(11):1500-4. PubMed ID: 6375336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of nifedipine of abnormal coronary vasoconstriction in patients with coronary artery disease.
    Gunther S; Green L; Muller JE; Mudge GH; Grossman W
    Circulation; 1981 Apr; 63(4):849-55. PubMed ID: 7471341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selective alpha1- and alpha2-adrenergic blockade on coronary flow reserve after coronary stenting.
    Gregorini L; Marco J; Farah B; Bernies M; Palombo C; Kozàkovà M; Bossi IM; Cassagneau B; Fajadet J; Di Mario C; Albiero R; Cugno M; Grossi A; Heusch G
    Circulation; 2002 Dec; 106(23):2901-7. PubMed ID: 12460869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postjunctional selectivity of alpha-blockade with prazosin, trimazosin, and UK-33,274 in man.
    Singleton W; Saxton CA; Hernandez J; Prichard BN
    J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S145-51. PubMed ID: 6175830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade.
    Constantine JW; Lebel W; Weeks R
    J Cardiovasc Pharmacol; 1984; 6(1):142-50. PubMed ID: 6199597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of alpha 2-adrenoceptors in normal and atherosclerotic human coronary circulation.
    Indolfi C; Piscione F; Villari B; Russolillo E; Rendina V; Golino P; Condorelli M; Chiariello M
    Circulation; 1992 Oct; 86(4):1116-24. PubMed ID: 1356656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking correlates with flow-mediated brachial artery vasoactivity but not cold pressor vasoactivity in men with coronary artery disease.
    Corretti MC; Plotnick GD; Vogel RA
    Int J Card Imaging; 1998 Feb; 14(1):11-7. PubMed ID: 9559374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nonselective and selective alpha 1-adrenergic blockade on coronary blood flow during exercise.
    Bache RJ; Dai XZ; Herzog CA; Schwartz JS
    Circ Res; 1987 Nov; 61(5 Pt 2):II36-41. PubMed ID: 2822283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardiovascular effects of trimazosin.
    Constantine JW; Hess HJ
    Eur J Pharmacol; 1981 Sep; 74(2-3):227-38. PubMed ID: 6120084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alpha adrenergic blockade upon coronary hemodynamics.
    Orlick AE; Ricci DR; Alderman EL; Stinson EB; Harrison DC
    J Clin Invest; 1978 Aug; 62(2):459-67. PubMed ID: 27535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.